tm
Seeing Is Believing
tm
Seeing Is Believing
Catabasis Pharmaceuticals's activity chart (see below) currently has 14 price targets and 19 ratings on display.
Analysts average stock forecasts to be materialized ratio is 37.5% with an average time for these price targets to be met of 93.5 days.
Most recent stock forecast was given by from HC WAINWRIGHT on 25-Aug-2021. First documented stock forecast 20-Jul-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 25-Aug-2021
$13
$5.93 (83.88%)
$24
5 years 1 months 11 days ago
(25-Aug-2021)
1/2 (50%)
$3.74 (40.39%)
26
Buy Since 12-May-2021
$36
$28.93 (409.19%)
5 years 4 months 25 days ago
(12-May-2021)
0/1 (0%)
$25.38 (238.98%)
$5
$-2.07 (-29.28%)
5 years 6 months 27 days ago
(10-Mar-2021)
0/4 (0%)
$-13.12 (-72.41%)
Buy Since 20-Jul-2015
$1.15
$-5.92 (-83.73%)
$15
5 years 11 months 4 days ago
(02-Nov-2020)
2/4 (50%)
$-7.01 (-85.91%)
311
Buy Since 02-Feb-2017
$150
$142.93 (2021.64%)
8 years 10 months 16 days ago
(20-Nov-2017)
1/2 (50%)
$47.4 (46.20%)
37
What is CATB (Catabasis Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on CATB (Catabasis Pharmaceuticals)?
Which analyst has the most public recommendations on CATB (Catabasis Pharmaceuticals)?
Which analyst is the currently most bullish on CATB (Catabasis Pharmaceuticals)?
Which analyst is the currently most reserved on CATB (Catabasis Pharmaceuticals)?
